TIVC — Tivic Health Systems Inc

Tivic Health Systems Inc (TIVC) is a medical devices company listed on NASDAQ. It is led by Michael Kevin Handley, based in 47685 Lakeview Blvd., Fremont, CA, United States, 94538, with about 52 employees. Valion Bio, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.

Use this TIVC page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TIVC quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TIVC SEC filings page. Lician reads the product cache first so this HTML stays unique to Tivic Health Systems Inc even when a live quote feed is slow.